Navigation Links
IntelliCyt Launches Novel Assay System to Accelerate Cell Line Development
Date:3/16/2017

IntelliCyt, a Sartorius Company, and a leading provider of integrated platforms that accelerate drug discovery, antibody screening and immuno-oncology research today announced the launch of the Cy-Clone Plus assay system for ranking and selection of clones for cell line development using the iQue Screener PLUS platform. A key factor in reducing the production costs of biopharmaceuticals is the development of cell lines producing a high yield of product. The Cy-Clone PLUS selection strategy is designed to identify clones that are highly productive and have optimal growth characteristics.

IntelliCyt’s iQue Screener PLUS platform is an integrated instrument, software, and reagent system that offers rapid, multiplexed analysis of cell and bead-based samples in 96, and 384 well plates. The iQue Screener’s proprietary sampling technology uniquely enables efficient assessment of cells in suspension, and miniaturizes the assay format, which conserves precious samples for further analysis. Profiling phenotypic and functional endpoints of cells, while simultaneously analyzing secreted proteins through the use of bead-based assays, generates rich information from the fewest numbers of cells. Plates are processed quickly, and software-assisted automation, analysis, and experiment-level visualization tools instantly rank and reveal the best clones for further analysis.

“Cy-Clone PLUS will greatly streamline the clone ranking and selection workflow for cell line development,” said R. Terry Dunlay, President and CEO of IntelliCyt. “By measuring the critical productivity attributes of each clone, finding the healthiest producers is fast, cost effective, and easy.”

About IntelliCyt

IntelliCyt Corporation,a Sartorius Company, manufactures and sells instrumentation, software and reagents that facilitate the study of cells and their components to gain a better understanding of normal and disease processes. This information speeds the discovery and development of new drugs and provides new insight for the diagnosis of diseases. IntelliCyt’s products are used worldwide throughout the pharmaceutical and biotechnology industries and in nonprofit research labs. For more information, please visit http://www.intellicyt.com.

About Sartorius
The Sartorius Group is a leading international pharmaceutical and laboratory equipment provider with two divisions: Bioprocess Solutions and Lab Products & Services. Bioprocess Solutions with its broad product portfolio focusing on single-use solutions helps customers produce biotech medications and vaccines safely and efficiently. Lab Products & Services, with its premium laboratory instruments, consumables and services, concentrates on serving the needs of laboratories performing research and quality assurance at pharma and biopharma companies and on those of academic research institutes. Founded in 1870, the company earned sales revenue of more than 1.3 billion euros in 2016. Around 7,000 people work for the Group, which has its own manufacturing and sales sites in around 110 countries.

Read the full story at http://www.prweb.com/releases/2017/03/prweb14129356.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. IntelliCyt Launches iQue® Screener PLUS to Accelerate Suspension-cell Screening and Combinatorial Profiling for Immunological Applications
2. Genedata and IntelliCyt Forge Alliance to Transform Cell-based Screening in Drug Discovery
3. SpectraGenetics Joins IntelliCyt’s Technology Alliance Partner Program
4. IntelliCyt Corporation Completes $7.4 Million in New Financing
5. IntelliCyt and FIMM Announce a Collaboration to Advance Personalized Medicine in Cancer Treatment
6. AstraZeneca Enters into an Agreement with IntelliCyt for the Development of High Throughput Biology Applications
7. Massachusetts General Hospital Enters Into a Technology Alliance Partnership with IntelliCyt for the Development of CRISPR Functional Screening Applications
8. IntelliCyt Announces a New Addition to the iQue® Screener PLUS Platform During CYTO 2016
9. Notable Labs Enters into a Collaboration Agreement with IntelliCyt to Develop a Phenotypic Personalized Medicine Platform for Cancer Patients
10. Darrow Wealth Management Launches New Website
11. Guidepoint Global Launches Two Major Enhancements to its Client Research Portal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... ... July 25, 2017 , ... ... microbiome and improve efficiency of livestock farming while reducing the use of antibiotics ... additional intellectual property from Cornell University. , These new proprietary technologies expand ...
(Date:7/24/2017)... Intralytix, Inc. announced that it received $17.5 million in ... This investment marks the beginning of a close collaboration ... for various benefits in human health and in other ... As a global key player in yeasts ... for baking, food taste & pleasure, health care, and ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... today announced that the stock market news outlet had initiated coverage on ... testing that screens and identifies exposure, progression and risk analysis from specific ...
(Date:7/20/2017)... ... 20, 2017 , ... Resoundant, Inc. is pleased to introduce ... the U.S. that offer MR Elastography for liver fibrosis staging. MR Elastography ... staging liver fibrosis assessment. , “MRE:connect was created in response to an increasing ...
Breaking Biology Technology:
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
(Date:3/23/2017)... 2017 Research and Markets has announced the ... Trends - Industry Forecast to 2025" report to their offering. ... The Global ... of around 8.8% over the next decade to reach approximately $14.21 ... market estimates and forecasts for all the given segments on global ...
(Date:3/22/2017)... Optimove , provider of the ... as 1-800-Flowers and AdoreMe, today announced two new ... Using Optimove,s machine learning algorithms, these features allow ... recommendations to their customers based not just on ... intent drawn from a complex web of data ...
Breaking Biology News(10 mins):